Herbal Therapy Is Associated With the Risk of CKD in Adults Not Using Analgesics in Taiwan

2006, USRDS 2005 Annual Data Report: International comparisons, Am J Kidney Dis, 47, S215

Chi, 1996, The practice of Chinese medicine in Taiwan, Soc Sci Med, 43, 1329, 10.1016/0277-9536(95)00429-7

Kaphle, 2006, Herbal medicine research in Taiwan, Evid Based Complement Alternat Med, 3, 149, 10.1093/ecam/nek016

Chang, 2001, Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications, Am J Nephrol, 21, 441, 10.1159/000046647

Pan, 2003, Prevalence and awareness of diabetes and mean fasting glucose by age, sex, and region: Results from the Nutrition and Health Survey in Taiwan, 1993-1996, Diabet Med, 20, 182, 10.1046/j.1464-5491.2003.00772.x

Lichtenstein, 2006, Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee, Circulation, 114, 82, 10.1161/CIRCULATIONAHA.106.176158

Huang, 1997, Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan, J Clin Pharmacol, 37, 344, 10.1002/j.1552-4604.1997.tb04312.x

Cheng, 2000, Review: Drug therapy in Chinese traditional medicine, J Clin Pharmacol, 40, 445, 10.1177/00912700022009198

Jafar, 2005, Serum creatinine as marker of kidney function in South Asians: A study of reduced GFR in adults in Pakistan, J Am Soc Nephrol, 16, 1413, 10.1681/ASN.2004121100

Fitzmaurice, 2000, The meaning and interpretation of interaction, Nutrition, 16, 313, 10.1016/S0899-9007(99)00293-2

Abebe, 2002, Herbal medication: Potential for adverse interactions with analgesic drugs, J Clin Pharm Ther, 27, 391, 10.1046/j.1365-2710.2002.00444.x

Hwang, 2006, Prevalence of obesity and metabolic syndrome in Taiwan, J Formos Med Assoc, 105, 626, 10.1016/S0929-6646(09)60161-3

Li, 2005, Prevalence of silent kidney disease in Hong Kong: The screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program, Kidney Int Suppl 94, S36, 10.1111/j.1523-1755.2005.09410.x

Go, 2006, Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease, Curr Opin Nephrol Hypertens, 15, 296, 10.1097/01.mnh.0000222698.30207.aa

Colson, 2005, Kidney injury from alternative medicines, Adv Chronic Kidney Dis, 12, 261, 10.1016/j.ackd.2005.03.006

Ko, 2004, A U.S. perspective on the adverse reactions from traditional Chinese medicines, J Chin Med Assoc, 67, 109

Wojcikowski, 2004, Medicinal herbal extracts—Renal friend or foe?, Nephrology (Carlton), 9, 313, 10.1111/j.1440-1797.2004.00310.x

Richard, 2005, Effects of natural health products on blood pressure, Ann Pharmacother, 39, 712, 10.1345/aph.1D067

Magee, 2005, Herbal therapy: A review of potential health risks and medicinal interactions, Orthod Craniofac Res, 8, 60, 10.1111/j.1601-6343.2005.00315.x

Huang, 1997, Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan, J Clin Pharmacol, 37, 344, 10.1002/j.1552-4604.1997.tb04312.x

Hartley, 2000, Hypertension risk status and effect of caffeine on blood pressure, Hypertension, 36, 137, 10.1161/01.HYP.36.1.137

Choudhury, 2006, Drug-associated renal dysfunction and injury, Nature Clin Pract Nephrol, 2, 80, 10.1038/ncpneph0076

Garvey, 2001, Heavy metal hazards of Asian traditional remedies, Int J Environ Health Res, 11, 63, 10.1080/09603120020019656

Lin, 1999, Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency, Ann Intern Med, 130, 7, 10.7326/0003-4819-130-1-199901050-00003

Lin, 2003, Environmental lead exposure and progression of chronic renal diseases in patients without diabetes, N Engl J Med, 348, 277, 10.1056/NEJMoa021672

Yu, 2004, Environmental exposure to lead and progression of chronic renal diseases: A four-year prospective longitudinal study, J Am Soc Nephrol, 15, 1016, 10.1097/01.ASN.0000118529.01681.4F

Liou, 1996, Blood lead levels in Taiwanese adults: Distribution and influencing factors, Sci Total Environ, 180, 211, 10.1016/0048-9697(96)80245-2

Domrongkitchaiporn, 2005, Risk factors for development of decreased kidney function in a southeast Asian population: A 12-year cohort study, J Am Soc Nephrol, 16, 791, 10.1681/ASN.2004030208

Chadban, 2003, Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study, J Am Soc Nephrol, 14, S131, 10.1097/01.ASN.0000070152.11927.4A

Shakespeare, 2001, Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours, Lancet, 357, 1349, 10.1016/S0140-6736(00)04522-0